Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Alternative treatments show promise for hair growth beyond traditional methods.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

MorrF improves hair growth better than minoxidil alone.

Treating melasma in men is difficult, especially for the deeper skin layers, and may need more than just topical treatments.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The hair growth product was effective and safe, increasing hair growth, thickness, and density while reducing hair fall.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Adult hair follicle cells can create new hair follicles from corneal cells with the right support.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

Men with testicular cancer were less likely to experience baldness and severe acne.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Transgender women can still get testicular cancer, so proper screening is important.

Bald men may have a lower risk of testicular cancer.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.